/XBRAF
XBRAF Stock - Xebra Brands Ltd.
Healthcare|Drug Manufacturers - Specialty & GenericOTC
$0.01-52.00%
$0.01 (-52.00%) • Dec 19
55
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.0
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.01
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for XBRAF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.01 – $0.01
TARGET (TP)$0.01
STOP LOSS$0.01
RISK/REWARD1:-1.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta-1.90
52W High$0.06
52W Low$0.01
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $106,855 | $158,949 | N/A | N/A | N/A |
| Gross Profit | $-308,422 | $-16,029 | $-603,374 | $-550,308 | $-11,778 |
| Gross Margin | -288.6% | -10.1% | N/A | N/A | N/A |
| Operating Income | $-1,554,538 | $-2,929,338 | $-3,447,620 | $-1,803,420 | $-1,530,337 |
| Net Income | $-1,957,380 | $-4,024,270 | $-6,142,658 | $-1,860,048 | $-2,788,188 |
| Net Margin | -1831.8% | -2531.8% | N/A | N/A | N/A |
| EPS | $-0.04 | $-0.11 | $-0.25 | $-0.07 | $-0.11 |
Company Overview
Xebra Brands Ltd. engages in the cultivation, processing, manufacturing, design, and delivery of cannabis products in Canada. It provides cannabis infused beverages, including seltzers, soft drinks, iced teas, lemonades, waters, and energy and sport drinks; and wellness products that include capsules, tinctures, topicals, and intimate oils for personal care. The company offers its products under the HighJack, MadCap, Vicious Citrus, Conquer, HolaHi, and HighCastle brands. Xebra Brands Ltd. was incorporated in 2019 and is headquartered in Vancouver, Canada.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
XBRAFBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.00
Q1 2025
EPS Surprise History
Q1 23
No data
Q2 23
No data
Q3 23
No data
Q4 23
No data
Q1 24
No data
Q2 24
No data
Q3 24
No data
Q1 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Jan 27, 2026 | — | — | — | — |
Q4 2025 | Oct 27, 2025 | — | — | — | — |
Q2 2025 | Jun 26, 2025 | — | — | — | — |
Q1 2025 | Jan 29, 2025 | — | — | — | — |
Q1 2025 | Jan 27, 2025 | — | $-0.00 | — | — |
Q3 2024 | Jul 30, 2024 | — | $-0.00 | — | — |
Q2 2024 | Jun 28, 2024 | — | $-0.00 | — | — |
Q1 2024 | Jan 29, 2024 | — | $-0.01 | — | — |
Q4 2023 | Oct 30, 2023 | — | $-0.00 | — | — |
Q3 2023 | Aug 24, 2023 | — | $-0.01 | — | — |
Q2 2023 | May 31, 2023 | — | $-0.01 | — | — |
Q1 2023 | Feb 28, 2023 | — | $-0.03 | — | — |
Q4 2022 | Nov 30, 2022 | — | $-0.01 | — | — |
Q3 2022 | Aug 31, 2022 | — | $-0.02 | — | — |
Q2 2022 | May 31, 2022 | — | $-0.02 | — | — |
Q1 2022 | Feb 28, 2022 | — | $-0.08 | — | — |
Q4 2021 | Nov 30, 2021 | — | $-0.05 | — | — |
Q3 2021 | Aug 31, 2021 | — | $-0.02 | — | — |
Q2 2021 | May 31, 2021 | — | $-0.01 | — | — |
Q1 2021 | Feb 28, 2021 | — | $-0.01 | — | — |
Latest News
Loading news...
Frequently Asked Questions about XBRAF
What is XBRAF's current stock price?
Xebra Brands Ltd. (XBRAF) is currently trading at $0.01 per share. The stock has moved -52.00% today.
What is the analyst price target for XBRAF?
No analyst price targets are currently available for this stock.
What sector is Xebra Brands Ltd. in?
Xebra Brands Ltd. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.
What is XBRAF's market cap?
Xebra Brands Ltd. has a market capitalization of $0.00 billion, making it a small-cap company.
Does XBRAF pay dividends?
No, Xebra Brands Ltd. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorERBB
American Green, Inc.
$0.00
Mkt Cap: $0.0B
FITX
Creative Edge Nutrition, Inc.
$0.00
Mkt Cap: $0.0B
GEATF
Radiko Holdings Corp.
$0.00
Mkt Cap: $0.0B
GRCU
Green Cures & Botanical Distribution Inc.
$0.00
Mkt Cap: $0.0B
IDYLF
Imaging Dynamics Company Ltd.
$0.02
Mkt Cap: $0.0B
SLNX
Solanbridge Group, Inc.
$0.00
Mkt Cap: $0.0B
SNNC
Sibannac, Inc.
$0.01
Mkt Cap: $0.0B
STEK
Stemtech Corporation
$0.00
Mkt Cap: $0.0B
TRLFF
Maven Brands Inc.
$0.00
Mkt Cap: $0.0B
VRTHF
Indigenous Bloom Hemp Corp.
$0.00
Mkt Cap: $0.0B
Explore stocks similar to XBRAF for comparison